Petr Morávek

554 total citations
38 papers, 411 citations indexed

About

Petr Morávek is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Petr Morávek has authored 38 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Petr Morávek's work include Renal cell carcinoma treatment (15 papers), Multiple and Secondary Primary Cancers (7 papers) and Cancer Genomics and Diagnostics (5 papers). Petr Morávek is often cited by papers focused on Renal cell carcinoma treatment (15 papers), Multiple and Secondary Primary Cancers (7 papers) and Cancer Genomics and Diagnostics (5 papers). Petr Morávek collaborates with scholars based in Czechia, Germany and United States. Petr Morávek's co-authors include Miroslav Podhola, J. Schubert, Gregor Weirich, Kerstin Junker, Winfried Hindermann, Jiří Zachariáš, Petr Gadas, J. Schubert, Hartwig Kosmehl and Mahul B. Amin and has published in prestigious journals such as Chemical Geology, European Urology and Economic Geology.

In The Last Decade

Petr Morávek

32 papers receiving 396 citations

Peers

Petr Morávek
Comparison fields: 5 of 82
  • Pulmonary and Respiratory Medicine 231
  • Molecular Biology 147
  • Geophysics 98
  • Cancer Research 88
  • Artificial Intelligence 83
Replace Yanjie Niu with:
Yanjie Niu China
Steven L. Stroup United States
Genwen Chen China
Sho Endo Japan
Jay R. Harris United States
Jie Ye China
Xiaofei Qiu China
Chong Jin United States
Junlan Qiu China
Xiao‐Yan Jiang China
Yanjie Niu China View profile →
Citations per field, relative to Petr Morávek
Petr Morávek · 1×
Citations per year, relative to Petr Morávek
Petr Morávek · 1×

Countries citing papers authored by Petr Morávek

Since Specialization
Citations

This map shows the geographic impact of Petr Morávek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Morávek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Morávek more than expected).

Fields of papers citing papers by Petr Morávek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petr Morávek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Morávek. The network helps show where Petr Morávek may publish in the future.

Co-authorship network of co-authors of Petr Morávek

This figure shows the co-authorship network connecting the top 25 collaborators of Petr Morávek. A scholar is included among the top collaborators of Petr Morávek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Morávek. Petr Morávek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 23
2
Perkutánní radiofrekvenční ablace (RFA) v léčbě nádoru ledvin - vlastní zkušenosti
1
3 32
4 6
5 2
6 23
7
[A case of an asynchronic triple tumorous disorder: a rectal adenocarcinoma, a carcinoma of the kidney and a prostatic adenocarcinoma--case report].
1
8 45
9 7
10 12
11
[Asynchronous occurrence of three neoplastic diseases: chronic B-cell lymphatic leukemia, renal carcinoma and prostatic adenocarcinoma].
5
12 22
13
Výskyt urolitiázy v kontinentní neovezice
0
14 6
15 50
16 2
17
[Conservative surgical treatment of kidney tumors: indications, techniques, results].
1
18
Urinary excretion of some metabolites of tryptophan in malignant diseases.
1
19 10
20 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026